Related references
Note: Only part of the references are listed.Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype-phenotype spectrum
Martin Krenn et al.
JOURNAL OF NEUROLOGY (2018)
Cooperative Domain Formation by Homologous Motifs in HOIL-1L and SHARPIN Plays A Crucial Role in LUBAC Stabilization
Hiroaki Fujita et al.
CELL REPORTS (2018)
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis
Nieves Peltzer et al.
NATURE (2018)
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
Philip A. Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death
Elodie Lafont et al.
EMBO JOURNAL (2017)
The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity
Rune Busk Damgaard et al.
CELL (2016)
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
K. Newton et al.
CELL DEATH AND DIFFERENTIATION (2016)
Poly-ubiquitination in TNFR1-mediated necroptosis
Yves Dondelinger et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death
Sebastian Kupka et al.
FEBS JOURNAL (2016)
The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis
Silvia Alvarez-Diaz et al.
IMMUNITY (2016)
LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation
Julia Zinngrebe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease
Qing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling
Nieves Peltzer et al.
TRENDS IN CELL BIOLOGY (2016)
Roles of linear ubiquitinylation, a crucial regulator of NF-κB and cell death, in the immune system
Katsuhiro Sasaki et al.
IMMUNOLOGICAL REVIEWS (2015)
Linear ubiquitination in immunity
Yutaka Shimizu et al.
IMMUNOLOGICAL REVIEWS (2015)
Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia
Bertrand Boisson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling
Yves Dondelinger et al.
MOLECULAR CELL (2015)
Necroptosis and its role in inflammation
Manolis Pasparakis et al.
NATURE (2015)
Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
Judy H. Cho et al.
NATURE MEDICINE (2015)
Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination
M. C. de Almagro et al.
CELL DEATH & DISEASE (2015)
LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes
Peter Draber et al.
CELL REPORTS (2015)
Regulation of tumour necrosis factor signalling: live or let die
Dirk Brenner et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death
James M. Murphy et al.
EMBO REPORTS (2014)
Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo
Apostolos Polykratis et al.
JOURNAL OF IMMUNOLOGY (2014)
Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice
Scott B. Berger et al.
JOURNAL OF IMMUNOLOGY (2014)
HOIP Deficiency Causes Embryonic Lethality by Aberrant TNFR1-Mediated Endothelial Cell Death
Nieves Peltzer et al.
CELL REPORTS (2014)
TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice
James A. Rickard et al.
ELIFE (2014)
Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis
Snehlata Kumari et al.
ELIFE (2014)
Mechanisms regulating skin immunity and inflammation
Manolis Pasparakis et al.
NATURE REVIEWS IMMUNOLOGY (2014)
RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition
Y. Dondelinger et al.
CELL DEATH AND DIFFERENTIATION (2013)
Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells
Yoshiteru Sasaki et al.
EMBO JOURNAL (2013)
Death Receptor-Ligand Systems in Cancer, Cell Death, and Inflammation
Henning Walczak
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Protective Roles for Caspase-8 and cFLIP in Adult Homeostasis
Ricardo Weinlich et al.
CELL REPORTS (2013)
Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency
Bertrand Boisson et al.
NATURE IMMUNOLOGY (2012)
Survival Function of the FADD-CASPASE-8-cFLIPL Complex
Christopher P. Dillon et al.
CELL REPORTS (2012)
The Multitasking Organ: Recent Insights into Skin Immune Function
Paola Di Meglio et al.
IMMUNITY (2011)
SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex
Fuminori Tokunaga et al.
NATURE (2011)
RIP3 mediates the embryonic lethality of caspase-8-deficient mice
William J. Kaiser et al.
NATURE (2011)
Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis
Andrew Oberst et al.
NATURE (2011)
SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis
Fumiyo Ikeda et al.
NATURE (2011)
Linear ubiquitination prevents inflammation and regulates immune signalling
Bjoern Gerlach et al.
NATURE (2011)
Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction
Tobias L. Haas et al.
MOLECULAR CELL (2009)
Involvement of linear polyubiquitylation of NEMO in NF-κB activation
Fuminori Tokunaga et al.
NATURE CELL BIOLOGY (2009)
Novel markers of normal and neoplastic human plasmacytoid dendritic cells
Teresa Marafioti et al.
BLOOD (2008)
TNF-α induces two distinct caspase-8 activation pathways
Lai Wang et al.
CELL (2008)
TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development
Anne Grosse-Wilde et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice
Ulrike Lichti et al.
NATURE PROTOCOLS (2008)
Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis
R. E. Seymour et al.
GENES AND IMMUNITY (2007)
Is TNFα really a good therapeutic target in motoneuronal degeneration?: A case of amyotrophic lateral sclerosis in a patient with RA receiving infliximab
M. Dziadzio et al.
RHEUMATOLOGY (2006)
Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling
A Nenci et al.
HUMAN MOLECULAR GENETICS (2006)
Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein
M Hafner et al.
GENESIS (2004)
Kinase RIP3 is dispensable for normal NF-KBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4
K Newton et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Caspase-8 serves both apoptotic and nonapoptotic roles
TB Kang et al.
JOURNAL OF IMMUNOLOGY (2004)
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
O Micheau et al.
CELL (2003)
Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity
L Salmena et al.
GENES & DEVELOPMENT (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
U Chaudhari et al.
LANCET (2001)
Share Paper
